{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T09:24:58Z","timestamp":1795166698625,"version":"4.10.3"},"reference-count":42,"publisher":"American Chemical Society (ACS)","issue":"11","license":[{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Akademie Ved Cesk? Republiky","award":["86652036"],"award-info":[{"award-number":["86652036"]}],"id":[{"id":"https:\/\/ror.org\/053avzc18","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Ministerstvo ?kolstv?, Ml?de?e a Telov?chovy","award":["LM2023053"],"award-info":[{"award-number":["LM2023053"]}]},{"name":"Ministerstvo ?kolstv?, Ml?de?e a Telov?chovy","award":["LUAUS23254"],"award-info":[{"award-number":["LUAUS23254"]}]},{"name":"Grantov? Agentura Cesk? Republiky","award":["24-12155S"],"award-info":[{"award-number":["24-12155S"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,11,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Histone deacetylase 11 (HDAC11) is a lysine defatty-acylase with emerging roles in immunity, metabolism, and disease, creating a need for rigorously validated isoform-selective inhibitors. Elevenostat\/JB3-22 has been used as an HDAC11 inhibitor, but its HDAC isoform selectivity has remained insufficiently defined. Here, we re-evaluated Elevenostat using recombinant human HDAC isoforms, orthogonal HDAC11 activity assays, and cellular pharmacodynamic readouts. Elevenostat inhibited HDAC11 only weakly, with IC50 values of 10.2 \u00b5M in a fluorogenic assay and 32.1 \u00b5M in an HPLC-based fatty-acyl substrate assay. Full HDAC1\u201311 profiling revealed preferential inhibition of the class IIb enzymes HDAC6 and HDAC10 (IC50 = 3.2 and 8.9 nM, respectively), as well as class I HDACs, whereas HDAC11 was the least sensitive isoform. In cells, Elevenostat increased acetylated \u03b1-tubulin and histone acetylation and reduced cell viability, consistent with HDAC6 and class I HDAC engagement. These data demonstrate that Elevenostat\/JB3-22 is not an HDAC11-selective chemical probe, but a class I\/class IIb-biased multi-HDAC hydroxamate. Biological conclusions based solely on Elevenostat treatment should therefore be interpreted with caution.<\/jats:p>","DOI":"10.1021\/acschembio.6c00703","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:02:04Z","timestamp":1791975724000},"page":"3079-3087","source":"Crossref","is-referenced-by-count":0,"title":["Elevenostat Is an HDAC6\/Class I-Biased Multi-HDAC Inhibitor Rather than an HDAC11-Selective Chemical Probe"],"prefix":"10.1021","volume":"21","author":[{"given":"Miroslava","family":"Vosahlikova","sequence":"first","affiliation":[{"name":"Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV , Prumyslova 595 , ,","place":["Vestec, Czech Republic, 252 50"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9936-9518","authenticated-orcid":true,"given":"Zsofia","family":"Kutilova","sequence":"additional","affiliation":[{"name":"Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV , Prumyslova 595 , ,","place":["Vestec, Czech Republic, 252 50"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Kudlacova","sequence":"additional","affiliation":[{"name":"Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV , Prumyslova 595 , ,","place":["Vestec, Czech Republic, 252 50"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbora","family":"Havlinova","sequence":"additional","affiliation":[{"name":"Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV , Prumyslova 595 , ,","place":["Vestec, Czech Republic, 252 50"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marat","family":"Meleshin","sequence":"additional","affiliation":[{"name":"Martin-Luther-University Halle-Wittenberg , , Kurt-Mothes-Str. 3a , ,","place":["Halle\/Saale, Germany, 06120"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9804-6346","authenticated-orcid":true,"given":"Zora","family":"Novakova","sequence":"additional","affiliation":[{"name":"Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV , Prumyslova 595 , ,","place":["Vestec, Czech Republic, 252 50"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0831-4034","authenticated-orcid":true,"given":"Ivan","family":"Snajdr","sequence":"additional","affiliation":[{"name":"Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences , Flemingovo n. 2 , ,","place":["Prague 6, Czech Republic, 16000"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0919-7076","authenticated-orcid":true,"given":"Mike","family":"Schutkowski","sequence":"additional","affiliation":[{"name":"Martin-Luther-University Halle-Wittenberg , , Kurt-Mothes-Str. 3a , ,","place":["Halle\/Saale, Germany, 06120"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2751-3060","authenticated-orcid":true,"given":"Cyril","family":"Barinka","sequence":"additional","affiliation":[{"name":"Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV , Prumyslova 595 , ,","place":["Vestec, Czech Republic, 252 50"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,10,14]]},"reference":[{"issue":"28","key":"2026112003062179200_cit1","doi-asserted-by":"publisher","first-page":"25748","DOI":"10.1074\/jbc.M111871200","article-title":"Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family","volume":"277","author":"Gao","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"1","key":"2026112003062179200_cit2","doi-asserted-by":"publisher","first-page":"9496","DOI":"10.1038\/s41467-024-53903-0","article-title":"Distribution and diversity of classical deacylases in bacteria","volume":"15","author":"Graf","year":"2024","journal-title":"Nat. Commun."},{"key":"2026112003062179200_cit3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1741-7007-4-24","article-title":"Comparative genomics of the class 4 histone deacetylase family indicates a complex evolutionary history","volume":"4","author":"Ledent","year":"2006","journal-title":"BMC Biol."},{"issue":"12","key":"2026112003062179200_cit4","doi-asserted-by":"publisher","first-page":"5487","DOI":"10.1073\/pnas.1815365116","article-title":"HDAC11 regulates type I interferon signaling through defatty-acylation of SHMT2","volume":"116","author":"Cao","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"2026112003062179200_cit5","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1021\/acschembio.7b00942","article-title":"Histone Deacetylase 11 Is a Fatty-Acid Deacylase","volume":"13","author":"Kutil","year":"2018","journal-title":"ACS Chem. Biol."},{"issue":"7","key":"2026112003062179200_cit6","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.chembiol.2018.04.007","article-title":"Histone Deacetylase 11 Is an \u03b5-N-Myristoyllysine Hydrolase","volume":"25","author":"Moreno-Yruela","year":"2018","journal-title":"Cell Chem. Biol."},{"issue":"1","key":"2026112003062179200_cit7","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/ni.1673","article-title":"The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance","volume":"10","author":"Villagra","year":"2009","journal-title":"Nat. Immunol."},{"issue":"2","key":"2026112003062179200_cit8","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1182\/blood-2016-08-731505","article-title":"T cells lacking HDAC11 have increased effector functions and mediate enhanced alloreactivity in a murine model","volume":"130","author":"Woods","year":"2017","journal-title":"Blood"},{"key":"2026112003062179200_cit9","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ebiom.2018.06.025","article-title":"Programming and Regulation of Metabolic Homeostasis by HDAC11","volume":"33","author":"Sun","year":"2018","journal-title":"EBioMedicine"},{"issue":"3","key":"2026112003062179200_cit10","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1111\/febs.15456","article-title":"HDAC11 is a novel regulator of fatty acid oxidative metabolism in skeletal muscle","volume":"288","author":"Hurtado","year":"2021","journal-title":"FEBS J."},{"key":"2026112003062179200_cit11","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102461","article-title":"HDAC11 negatively regulates antifungal immunity by inhibiting Nos2 expression via binding with transcriptional repressor STAT3","volume":"56","author":"Wu","year":"2022","journal-title":"Redox Biol."},{"issue":"19","key":"2026112003062179200_cit12","doi-asserted-by":"publisher","DOI":"10.1172\/JCI168192","article-title":"HDAC11 inhibition triggers bimodal thermogenic pathways to circumvent adipocyte catecholamine resistance","volume":"133","author":"Robinson","year":"2023","journal-title":"J. Clin. Invest."},{"issue":"15","key":"2026112003062179200_cit13","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202412903","article-title":"Targeting Histone Deacetylase 11 with a Highly Selective Inhibitor for the Treatment of MASLD","volume":"12","author":"Zhang","year":"2025","journal-title":"Adv. Sci."},{"issue":"12","key":"2026112003062179200_cit14","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1016\/j.bmcl.2018.05.021","article-title":"Discovery of novel N-hydroxy-2-arylisoindoline-4-carboxamides as potent and selective inhibitors of HDAC11","volume":"28","author":"Martin","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"23","key":"2026112003062179200_cit15","doi-asserted-by":"publisher","first-page":"16075","DOI":"10.1021\/acs.jmedchem.3c01491","article-title":"Development and Pharmacochemical Characterization Discover a Novel Brain-Permeable HDAC11-Selective Inhibitor with Therapeutic Potential by Regulating Neuroinflammation in Mice","volume":"66","author":"Bai","year":"2023","journal-title":"J. Med. Chem."},{"issue":"10","key":"2026112003062179200_cit16","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202400486","article-title":"Utilization of an optimized AlphaFold protein model for structure-based design of a selective HDAC11 inhibitor with anti-neuroblastoma activity","volume":"357","author":"Baselious","year":"2024","journal-title":"Arch. Pharm."},{"issue":"2","key":"2026112003062179200_cit17","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.3390\/ijms25021358","article-title":"Comparative Structure-Based Virtual Screening Utilizing Optimized AlphaFold Model Identifies Selective HDAC11 Inhibitor","volume":"25","author":"Baselious","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"2026112003062179200_cit18","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1021\/acschembio.9b00292","article-title":"Activity-Guided Design of HDAC11-Specific Inhibitors","volume":"14","author":"Son","year":"2019","journal-title":"ACS Chem. Biol."},{"issue":"42","key":"2026112003062179200_cit19","doi-asserted-by":"publisher","first-page":"50577","DOI":"10.1021\/acsomega.5c08195","article-title":"Substrate-Guided Development of HDAC11-Selective Inhibitors Featuring \u03b1-Amino Amide Zinc-Binding Groups","volume":"10","author":"Hilscher","year":"2025","journal-title":"ACS Omega"},{"issue":"11","key":"2026112003062179200_cit20","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1021\/acschembio.0c00719","article-title":"Garcinol Is an HDAC11 Inhibitor","volume":"15","author":"Son","year":"2020","journal-title":"ACS Chem. Biol."},{"issue":"13","key":"2026112003062179200_cit21","doi-asserted-by":"publisher","first-page":"5950","DOI":"10.3390\/ijms26135950","article-title":"Discovery and Characterization of Novel Non-Hydroxamate HDAC11 Inhibitors","volume":"26","author":"Kopranovic","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"2026112003062179200_cit22","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1021\/jacsau.4c01148","article-title":"Discovery of De Novo Macrocycle Inhibitors of Histone Deacetylase 11","volume":"5","author":"Dankova","year":"2025","journal-title":"JACS Au"},{"issue":"4","key":"2026112003062179200_cit23","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1021\/acschembio.2c00840","article-title":"Trapoxin A Analogue as a Selective Nanomolar Inhibitor of HDAC11","volume":"18","author":"Ho","year":"2023","journal-title":"ACS Chem. Biol."},{"issue":"6","key":"2026112003062179200_cit24","doi-asserted-by":"publisher","first-page":"6816","DOI":"10.1021\/acs.jmedchem.5c03107","article-title":"Discovery of a Hydroxamic Acid-Based HDAC11 Isoform-Selective Inhibitor with Oral Anti-AML Potency","volume":"69","author":"Chai","year":"2026","journal-title":"J. Med. Chem."},{"issue":"22","key":"2026112003062179200_cit25","doi-asserted-by":"publisher","first-page":"9891","DOI":"10.1021\/jm301098e","article-title":"Selective histone deacetylase 6 inhibitors bearing substituted urea linkers inhibit melanoma cell growth","volume":"55","author":"Bergman","year":"2012","journal-title":"J. Med. Chem."},{"issue":"1","key":"2026112003062179200_cit26","doi-asserted-by":"publisher","first-page":"8626","DOI":"10.1038\/s41598-017-09211-3","article-title":"Histone\/protein deacetylase 11 targeting promotes Foxp3+ Treg function","volume":"7","author":"Huang","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"2026112003062179200_cit27","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1080\/15384101.2019.1711315","article-title":"HDAC11 promotes meiotic apparatus assembly during mouse oocyte maturation via decreasing H4K16 and \u03b1-tubulin acetylation","volume":"19","author":"Sui","year":"2020","journal-title":"Cell Cycle"},{"issue":"6","key":"2026112003062179200_cit28","doi-asserted-by":"publisher","first-page":"8849","DOI":"10.18632\/aging.202697","article-title":"HDAC11 inhibition disrupts porcine oocyte meiosis via regulating \u03b1-tubulin acetylation and histone modifications","volume":"13","author":"Huang","year":"2021","journal-title":"Aging"},{"issue":"24","key":"2026112003062179200_cit29","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.151713","article-title":"Plasma cell dependence on histone\/protein deacetylase 11 reveals a therapeutic target in multiple myeloma","volume":"6","author":"Mostofa","year":"2021","journal-title":"JCI Insight"},{"key":"2026112003062179200_cit30","doi-asserted-by":"publisher","DOI":"10.1101\/2025.10.17.683079","article-title":"Inhibition of CGRP receptor ameliorates AD pathology by reprogramming lipid metabolism through HDAC11\/LXR\u03b2\/ABCA1 signaling","author":"Fan","year":"2025","journal-title":"bioRxiv"},{"key":"2026112003062179200_cit31","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202522985","article-title":"FGL2-HDAC11 Drives Immunothrombosis via NETs-Mediated Endothelial Capillarization in MASLD Fibrosis","volume":"13","author":"Li","year":"2026","journal-title":"Adv. Sci."},{"issue":"22","key":"2026112003062179200_cit32","doi-asserted-by":"publisher","first-page":"19895","DOI":"10.1021\/acsomega.9b02808","article-title":"Continuous Activity Assay for HDAC11 Enabling Reevaluation of HDAC Inhibitors","volume":"4","author":"Kutil","year":"2019","journal-title":"ACS Omega"},{"issue":"3","key":"2026112003062179200_cit33","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.bbrc.2004.09.155","article-title":"Members of the histone deacetylase superfamily differ in substrate specificity towards small synthetic substrates","volume":"324","author":"Riester","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"2026112003062179200_cit34","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S1074-5521(02)00305-8","article-title":"A Fluorogenic Histone Deacetylase Assay Well Suited for High-Throughput Activity Screening","volume":"10","author":"Wegener","year":"2003","journal-title":"Chem. Biol."},{"issue":"40","key":"2026112003062179200_cit35","doi-asserted-by":"publisher","first-page":"36044","DOI":"10.1021\/jacs.5c08929","article-title":"The Allosteric Regulator Inositol Phosphate Dramatically Affects the Efficacy and Selectivity of Inhibitors for Different HDAC Complexes","volume":"147","author":"Pytel","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"51","key":"2026112003062179200_cit36","doi-asserted-by":"publisher","first-page":"35402","DOI":"10.1074\/jbc.M807045200","article-title":"Pimelic diphenylamide 106 is a slow, tight-binding inhibitor of class I histone deacetylases","volume":"283","author":"Chou","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"37","key":"2026112003062179200_cit37","doi-asserted-by":"publisher","first-page":"26926","DOI":"10.1074\/jbc.M113.490706","article-title":"Histone deacetylase (HDAC) inhibitor kinetic rate constants correlate with cellular histone acetylation but not transcription and cell viability","volume":"288","author":"Lauffer","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"8","key":"2026112003062179200_cit38","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.3390\/biology12081049","article-title":"The Importance of the \u201cTime Factor\u201d for the Evaluation of Inhibition Mechanisms: The Case of Selected HDAC6 Inhibitors","volume":"12","author":"Cellupica","year":"2023","journal-title":"Biology"},{"issue":"5","key":"2026112003062179200_cit39","doi-asserted-by":"publisher","first-page":"4720","DOI":"10.3390\/ijms24054720","article-title":"Selectivity of Hydroxamate- and Difluoromethyloxadiazole-Based Inhibitors of Histone Deacetylase 6 In Vitro and in Cells","volume":"24","author":"Ptacek","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"2026112003062179200_cit40","doi-asserted-by":"publisher","first-page":"6136","DOI":"10.1038\/s41598-019-42237-3","article-title":"Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells","volume":"9","author":"Knox","year":"2019","journal-title":"Sci. Rep."},{"issue":"48","key":"2026112003062179200_cit41","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.1021\/acs.biochem.9b00786","article-title":"One-Atom Substitution Enables Direct and Continuous Monitoring of Histone Deacylase Activity","volume":"58","author":"Zessin","year":"2019","journal-title":"Biochemistry"},{"key":"2026112003062179200_cit42","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/978-1-0716-2788-4_29","article-title":"Determining Potency of Inhibitors Targeting Histone Deacetylase 6 by Quantification of Acetylated Tubulin in Cells","volume":"2589","author":"Mikesova","year":"2023","journal-title":"Methods Mol. Biol."}],"container-title":["ACS Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acschembio.6c00703","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/acbcct\/article-pdf\/21\/11\/3079\/68850362\/cb-2026-00703b.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/acbcct\/article-pdf\/21\/11\/3079\/68850362\/cb-2026-00703b.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T09:10:38Z","timestamp":1795165838000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/acbcct\/article\/21\/11\/3079\/5450664\/Elevenostat-Is-an-HDAC6-Class-I-Biased-Multi-HDAC"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,14]]},"references-count":42,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,10,14]]},"published-print":{"date-parts":[[2026,11,20]]}},"URL":"https:\/\/doi.org\/10.1021\/acschembio.6c00703","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acschembio.6c00703.s001","asserted-by":"subject"}]},"ISSN":["1554-8929","1554-8937"],"issn-type":[{"value":"1554-8929","type":"print"},{"value":"1554-8937","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,14]]}}}